In last trading session, GoodRx Holdings, Inc. (NASDAQ:GDRX) saw 15,791,433 shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $38 trading at $4.24 or 12.56% at ring of the bell on the day assigns it a market valuation of $14.83 Billion. That closing price of GDRX’s stock is at a discount of -69% from its 52-week high price of $64.22 and is indicating a premium of 11.82% from its 52-week low price of $33.51. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 6.12 Million shares which gives us an average trading volume of 3.5 Million if we extend that period to 3-months.
For GoodRx Holdings, Inc. (GDRX), analysts’ consensus is at an average recommendation of Overweight while assigning it a mean rating of 2.4. Splitting up the data highlights that, out of 14 analysts covering the stock, 1 rated the stock as a Sell while none recommended an Overweight rating for the stock. 6 suggested the stock as a Hold whereas 7 see the stock as a Buy. None analyst(s) advised it as an Underweight. The company is expected to be making an EPS of $0.06 in the current quarter.
GoodRx Holdings, Inc. (NASDAQ:GDRX) trade information
Wall Street analysts have assigned a consensus price target of $50.92 to the stock, which implies a rise of 34% to its current value. Analysts have been projecting $29 as a low price target for the stock while placing it at a high target of $70. It follows that stock’s current price would jump +84.21% in reaching the projected high whereas dropping to the targeted low would mean a loss of -23.68% for stock’s current value.
GoodRx Holdings, Inc. (GDRX) estimates and forecasts
11 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $147.91 Million for the same. And 11 analysts are in estimates of company making revenue of $162.08 Million in the next quarter that will end in March 01, 2021.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 0% during past 5 years. In 2020, company’s earnings growth rate is likely to be around 50.8% while estimates for its earnings growth in next 5 years are of 36.16%
GoodRx Holdings, Inc. (NASDAQ:GDRX)’s Major holders
Insiders are in possession of 0% of company’s total shares while institution are holding 281.02% percent of that, with stock having share float percentage of 281.02%. Investors also watch the number of corporate investors in a company very closely, which is 171 institutions for GoodRx Holdings, Inc. that are currently holding shares of the company. Silver Lake Group, LLC is the top institutional holder at GDRX for having 3.03 Million shares of worth $168.48 Million. And as of September 29, 2020, it was holding 6.9% of the company’s outstanding shares.
The second largest institutional holder is Vanguard Group, Inc. (The), which was holding about 2.41 Million shares on September 29, 2020. The number of shares represents firm’s hold over 5.48% of outstanding shares, having a total worth of $133.88 Million.
On the other hand, Growth Fund Of America Inc and Price (T.Rowe) Blue Chip Growth Fund Inc. are the top two Mutual Funds which own company’s shares. As of September 29, 2020, the former fund manager was holding 1092800 shares of worth $60.76 Million or 2.49% of the total outstanding shares. The later fund manager was in possession of 464.12 Thousand shares on September 29, 2020, making its stake of worth around $25.81 Million in the company or a holder of 1.06% of company’s stock.